Skip to main content
Caplight Logo









PhalconBio GmbH

PhalconBio GmbH

Private
WädenswilHealthcare & Life Scienceshttps://phalconbio.com/

Last Round

Grant

Feb 18, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PhalconBio GmbH is a biotechnology company that develops antimicrobial precision medicines using engineered bacteriophages to combat antibiotic resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

engineered bacteriophagephage therapyantimicrobial resistanceprecision medicineengineered phage therapeuticsEPTmultidrug-resistant bacteriasynthetic biologydrug discoveryantibiotic alternativespulmonary infectionbiotech startupsuperbug treatmentpreclinical researchphage tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhalconBio GmbH Comparables

Compare PhalconBio GmbH with similar companies based on industry and business-model similarity.

PhalconBio GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Paralos Bioscience
83%
PhageOne
81%
Locus Biosciences
81%

PhalconBio GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 18, 2025

PhalconBio GmbH Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors increased 1251% MoM, reaching 1.3K.

PhalconBio GmbH Filings

Explore SEC and related filing metadata, where available.

PhalconBio GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PhalconBio GmbH's valuation, stock price, and market status.

Is PhalconBio GmbH a public or private company?

PhalconBio GmbH is a private company.

What is the current stock price of PhalconBio GmbH?

PhalconBio GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is PhalconBio GmbH worth (valuation)?

Valuation information for PhalconBio GmbH is not publicly available.

Can I buy PhalconBio GmbH stock?

PhalconBio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PhalconBio GmbH's last funding round?

PhalconBio GmbH's most recent funding round was Grant on February 18, 2025.

Who are the main investors in PhalconBio GmbH?

Key investors in PhalconBio GmbH include PACE (Pathways to Antimicrobial Clinical Efficacy).

Will PhalconBio GmbH IPO soon?

No public IPO plans have been announced for PhalconBio GmbH.

How can I track PhalconBio GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PhalconBio GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWädenswil
Employee Range4
Year FoundedN/A
Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?